Session Details
Workshop 6 Surgical Treatment of Colorectal Liver Metastases: Is Preoperative Therapy Necessary? Weighing the Pros and Cons
Fri. Nov 20, 2026 2:15 PM - 3:30 PM JST
Fri. Nov 20, 2026 5:15 AM - 6:30 AM UTC
Fri. Nov 20, 2026 5:15 AM - 6:30 AM UTC
Room 8 (1F 108)
Moderator: (Department of Colorectal Surgery, National Cancer Center Hospital East)
[WS6-1]Management of comorbidities during neoadjuvant chemotherapy for resectable colorectal liver metastasis
*Hiroaki Nozawa1 (1. Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo)
[WS6-2]A Study of Cases with Synchronous Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy
*Shutaro Mochizuki1, Takeshi Suto1, Shotaro Hirata1, Keisuke Sato1, Masahiko Fukase1 (1. Department of Surgery, Yamagata Prefectural Central Hospital)
[WS6-3]Comparison of upfront surgery and neoadjuvant chemotherapy for resectable colorectal liver metastases: A propensity score-matched analysis
*Yasuyuki Takamizawa1 (1. Department of Colorectal Surgery, National Cancer Center Hospital)
[WS6-4]The role of consensus molecular subtype classification in individualizing upfront surgery for colorectal cancer with synchronous liver metastases
*Yusuke Takashima1 (1. Division of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital)
[WS6-5]Individualized Treatment Strategy and Outcomes for Synchronous Liver Metastases from Rectal Cancer
*Takashi Sakamoto1 (1. Department of Colorectal surgery, Gastroenterological center)
[WS6-6]Outcomes and Early Recurrence Risk Factors after Hepatectomy Following Preoperative Chemotherapy for H2 Liver-Limited Metastases from Colorectal Cancer
*Kazuki Kawasaki1 (1. Saitama Cancer Center)